13 january 15:30–16:15


 Studio, Ellipses
Evgeny Shlyakhto, Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"
Evgeny Kamkin, Deputy Minister of Health of the Russian Federation
Evgenia Kotova, Director of the Department for Monitoring, Analysis and Strategic Development of Health Care, Ministry of Health of the Russian Federation
Ricardo Martin, Managing Director, Medical Devices, Johnson & Johnson Russia & CIS
Farhad Riahi-Nejad, Global Head New Comm Partnership Models and Healthcare Systems Engagement, Novartis
The fight against cardiovascular diseases (CVDs) remains a key priority for the development of the healthcare system and the implementation of demographic objectives facing the Russian Federation. The spread of coronavirus infection has exacerbated the need for treatment and prevention of acute CVDs, as COVID-19 itself is a factor that increases the risks of adverse post-infectious cardiovascular events as well as triggering the debut of chronic and life-threatening cardiac diseases.

Discussion points:
• Prospective strategy for combating chronic non-communicable diseases: international and Russian experience.
• Accessibility of drug provision and introduction of innovations as a condition for achieving life expectancy targets.
• Medical information systems as a driver to improve the quality of medical care for patients with cardiovascular diseases.
• How to ensure a comprehensive approach to the management of cardiology and cardiovascular surgery patients in the context of the pandemic?